Sensitization Study of ATx201 in Healthy Volunteers

Sensitivity, Contact Clinical Trial

Official title:
A Single-Site Study To Evaluate the Sensitization Potential of Topically Applied ATx201 in Healthy Human Volunteers

Status Completed

Clinical Trial Summary

This is a Phase I, single-site study to evaluate the sensitization potential of topically applied ATx201 GEL, 2% and 4%, along with a placebo control, in healthy human subjects.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03375957
Study type	Interventional
Source	AntibioTx A/S
Contact
Status	Completed
Phase	Phase 1
Start date	January 8, 2018
Completion date	March 15, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04332445` - Dermatological Assessment of Primary Dermal Irritability Accumulated, Sensitization, Photoallergy and Phototoxicity.	N/A
Completed	`NCT05508243` - Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization of Hyaluronic Nasal Spray	N/A
Completed	`NCT05508230` - Evaluation of Cutaneous Acceptability and Perceived Effectiveness of a Nasal Spray (Health Care Products)	N/A
Completed	`NCT04248556` - Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization	N/A
Completed	`NCT04250623` - Dermatological Assessment of Photoallergy and Phototoxicity	N/A